腫瘤栓塞物質的全球市場
市場調查報告書
商品編碼
1132246

腫瘤栓塞物質的全球市場

Oncology Embolization Agents Market

出版日期: | 出版商: Life Science Intelligence | 英文 9 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

腫瘤栓塞物質,用於封閉病灶和腫瘤血管,靶向營養物質,增強藥物靶向遞送的有效性,並誘導細胞死亡。

本報告提供全球腫瘤栓塞物質市場相關調查,放射線栓塞,化學栓塞,粒子栓塞等的腫瘤栓塞物質相關以下主要的分析。

  • 數量(2020年~2026年)
  • 市場預測(2020年~2026年)
  • 主要的競爭形勢分析
  • 策略與Start-Ups的主要市場活動相關洞察
簡介目錄
Product Code: LSI-07252022-OncologyEmbolizationAgents

This report from Life Science Intelligence provides an analysis of the global market for oncology embolization agents, including radioembolization, chemoembolization and particle embolization devices. These solutions are used to occlude blood vessels to lesions and tumors to derive the target of nutrients, enhance the effectiveness of the targeted delivery of pharmaceuticals, and trigger cell death.

This market snapshot is intended to provide a high-level overview of the global oncology embolization agents market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups